Long-lasting potentiation effects induced in rats by kindling with an inverse agonist of the benzodiazepine receptor. 2002

Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
UMR 7593 CNRS, Medical Faculty Pitié-Salpêtrière, 75013 Paris, France. chapout@ext.jussieu.fr

The present work analyzed the changes in evoked field potentials of freely moving rats after kindling induced by a convulsant inverse agonist of the GABA(A)-benzodiazepine receptor complex, methyl beta-carboline-3-carboxylate (beta-CCM). Two doses of beta-CCM (2 mg/kg and 4 mg/kg) were used. In kindled and control animals, a stimulating electrode was implanted in the perforant pathway and a recording electrode in the dentate gyrus. Results showed that, after an acutely injected dose of 20 mg/kg pentylenetetrazol (PTZ), all kindled animals showed a decrease in population spike amplitude after 20 min. After 60 min, only fully kindled rats showed a long-lasting potentiation, also visible up to 24 h later, as compared to controls or nonkindled animals. Changes in glutamate and GABA receptor binding measured in previous experiments may explain this potentiation effect observed in fully kindled rats.

UI MeSH Term Description Entries
D007696 Kindling, Neurologic The repeated weak excitation of brain structures, that progressively increases sensitivity to the same stimulation. Over time, this can lower the threshold required to trigger seizures. Kindlings, Neurologic,Neurologic Kindling,Neurologic Kindlings
D008297 Male Males
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D002243 Carbolines A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles. Carboline,Pyrido(4,3-b)Indole,Beta-Carbolines,Pyrido(4,3-b)Indoles,Beta Carbolines
D003292 Convulsants Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. Convulsant,Convulsant Effect,Convulsant Effects,Effect, Convulsant,Effects, Convulsant
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D004567 Electrodes, Implanted Surgically placed electric conductors through which ELECTRIC STIMULATION is delivered to or electrical activity is recorded from a specific point inside the body. Implantable Electrodes,Implantable Stimulation Electrodes,Implanted Electrodes,Implanted Stimulation Electrodes,Electrode, Implantable,Electrode, Implantable Stimulation,Electrode, Implanted,Electrode, Implanted Stimulation,Electrodes, Implantable,Electrodes, Implantable Stimulation,Electrodes, Implanted Stimulation,Implantable Electrode,Implantable Stimulation Electrode,Implanted Electrode,Implanted Stimulation Electrode,Stimulation Electrode, Implantable,Stimulation Electrode, Implanted,Stimulation Electrodes, Implantable,Stimulation Electrodes, Implanted
D005071 Evoked Potentials Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported. Event Related Potential,Event-Related Potentials,Evoked Potential,N100 Evoked Potential,P50 Evoked Potential,N1 Wave,N100 Evoked Potentials,N2 Wave,N200 Evoked Potentials,N3 Wave,N300 Evoked Potentials,N4 Wave,N400 Evoked Potentials,P2 Wave,P200 Evoked Potentials,P50 Evoked Potentials,P50 Wave,P600 Evoked Potentials,Potentials, Event-Related,Event Related Potentials,Event-Related Potential,Evoked Potential, N100,Evoked Potential, N200,Evoked Potential, N300,Evoked Potential, N400,Evoked Potential, P200,Evoked Potential, P50,Evoked Potential, P600,Evoked Potentials, N100,Evoked Potentials, N200,Evoked Potentials, N300,Evoked Potentials, N400,Evoked Potentials, P200,Evoked Potentials, P50,Evoked Potentials, P600,N1 Waves,N2 Waves,N200 Evoked Potential,N3 Waves,N300 Evoked Potential,N4 Waves,N400 Evoked Potential,P2 Waves,P200 Evoked Potential,P50 Waves,P600 Evoked Potential,Potential, Event Related,Potential, Event-Related,Potential, Evoked,Potentials, Event Related,Potentials, Evoked,Potentials, N400 Evoked,Related Potential, Event,Related Potentials, Event,Wave, N1,Wave, N2,Wave, N3,Wave, N4,Wave, P2,Wave, P50,Waves, N1,Waves, N2,Waves, N3,Waves, N4,Waves, P2,Waves, P50
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
September 2000, Pharmacology, biochemistry, and behavior,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
May 1994, Behavioural brain research,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
June 2001, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
December 1989, British journal of pharmacology,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
May 1987, Pharmacology, biochemistry, and behavior,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
April 1998, European journal of pharmacology,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
December 1997, Journal of neurophysiology,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
October 1994, Naunyn-Schmiedeberg's archives of pharmacology,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
January 1999, Journal of psychiatric research,
Anne-Sophie Rössler, and Heinz Rüthrich, and Manfred Krug, and Robert H Dodd, and Georges Chapouthier, and Gisela Grecksch
April 1988, British journal of pharmacology,
Copied contents to your clipboard!